LNZA LanzaTech Global, Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 1843724 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY46.8%
TTM net income YoY88.9%
TTM EPS YoY99.0%
Revenue 3-yr CAGR2.9%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-51.2%
Net margin-14.4%
FCF margin-51.7%
EBITDA margin-44.0%
Returns
ROE-20.7%
ROA-7.0%
ROIC (approx.)-184.8%
Asset turnover0.49x
Leverage & solvency
Liabilities / assets39.0%
Debt / equity0.00x
Current ratio2.72x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.45x
Accruals ratio17.1%
Payout ratio—
Capex / revenue2.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $55.84M | $49.59M | $62.63M | $37.34M |
| R&D expense | $53.18M | $77.01M | $68.14M | $53.19M |
| SG&A expense | $47.05M | $49.98M | $50.44M | $26.80M |
| Operating income | -$79.16M | -$108.93M | -$106.38M | -$75.60M |
| Pretax income | -$44.72M | -$136.22M | -$131.20M | -$78.35M |
| Income tax | $0 | $0 | $0 | $0 |
| Net income | -$48.95M | -$137.73M | -$134.10M | -$76.36M |
| EBITDA | -$74.93M | -$103.37M | -$100.93M | -$70.94M |
| EPS (basic) | -22.27 | -69.71 | -0.79 | -12.37 |
| EPS (diluted) | -22.27 | -69.71 | -0.79 | -12.37 |
| Weighted avg. shares (diluted) | 2.20M | 1.98M | 176.02M | 9.30M |
| Balance sheet | ||||
| Cash & equivalents | $13.16M | $45.74M | $76.28M | $83.71M |
| Short-term investments | — | — | — | $0 |
| Inventory | $684,000 | $2.16M | $1.75M | $1.13M |
| Current assets | $39.69M | $99.33M | $172.70M | $123.90M |
| PP&E, net | $17.13M | $22.33M | $22.82M | $19.69M |
| Total assets | $100.21M | $174.68M | $241.62M | $176.86M |
| Current liabilities | $27.72M | $30.45M | $27.78M | $55.98M |
| Long-term debt | — | — | $25.15M | $50.00M |
| Total debt | — | — | $25.15M | $50.00M |
| Total liabilities | $90.93M | $161.24M | $127.15M | $124.95M |
| Shareholders' equity | -$3.89M | $13.45M | $114.47M | -$428.72M |
| Net debt | — | — | -$51.13M | -$33.71M |
| Shares outstanding | 2.32M | 1.95M | 196.64M | 10.42M |
| Cash flow statement | ||||
| Operating cash flow | -$64.85M | -$89.06M | -$97.30M | -$84.70M |
| Capital expenditure | $1.26M | $5.31M | $8.55M | $10.73M |
| Free cash flow | -$66.11M | -$94.37M | -$105.85M | -$95.44M |
| Investing cash flow | $11.15M | $28.35M | -$57.91M | -$10.69M |
| Financing cash flow | $25.62M | $30.21M | $148.19M | $50.55M |
| Depreciation & amortization | $4.23M | $5.57M | $5.45M | $4.66M |
| Stock-based compensation | $7.20M | $13.21M | $15.20M | $2.53M |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.